4.7 Article

Heat-shock protein 70-dependent dendritic cell activation by 5-aminolevulinic acid-mediated photodynamic treatment of human glioblastoma spheroids in vitro

期刊

BRITISH JOURNAL OF CANCER
卷 105, 期 7, 页码 961-969

出版社

SPRINGERNATURE
DOI: 10.1038/bjc.2011.327

关键词

aminolevulinic acid; glioma; photodynamic therapy; dendritic cells; HSP-70

类别

资金

  1. Research Committee of the Medical Faculty of the Heinrich-Heine-University, Dusseldorf, Germany
  2. German Federation of Neurosurgery (DGNC)

向作者/读者索取更多资源

BACKGROUND: T-cell responses contribute to the anti-tumoural effect of photodynamic therapy (PDT). For such responses to occur, dendritic cells (DCs) have to migrate to the tumour, take up tumour antigens and respond to danger signals with maturation, before they engage in T-cell activation. Here, we have studied the effect of 5-aminolevulinic acid (ALA)-mediated PDT on DCs in vitro in a human spheroid model of glioblastoma (GB). METHODS: Spheroids of the GB cell lines U87 and U251 were treated with ALA/PDT, and effects on attraction, uptake of tumour antigens and maturation of DCs were studied. To block heat-shock protein-70 (HSP-70) on the spheroids, neutralising antibodies were used. RESULTS: 5-Aminolevulinic acid /PDT-treated GB spheroids attracted DCs that acquired tumour antigens from the spheroids effectively. Moreover, co-culture with ALA/PDT-treated spheroids induced DC maturation as indicated by the upregulation of CD83 and co-stimulatory molecules as well as increased T-cell stimulatory activity of the DCs. Heat-shock protein-70 was upregulated on the spheroids after ALA/PDT treatment. Uptake of tumour antigens and DC maturation induced by the ALA/PDT-treated spheroids were inhibited when HSP-70 was blocked. CONCLUSION: ALA/PDT treatment of glioma spheroids promotes the three initial steps of the afferent phase of adaptive immunity, which is at least partially mediated by HSP-70. British Journal of Cancer (2011) 105, 961-969. doi:10.1038/bjc.2011.327 www.bjcancer.com Published online 23 August 2011 (C) 2011 Cancer Research UK

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Clinical Neurology

The impact of preoperative MRI-based apparent diffusion coefficients on local recurrence and outcome in patients with cerebral metastases

Julia Steinmann, Marion Rapp, Hosai Sadat, Franziska Staub-Bartelt, Bernd Turowski, Hans-Jakob Steiger, Daniel Hanggi, Michael Sabel, Marcel A. Kamp

Summary: This study analyzed the potential relationship between MRI-based apparent diffusion coefficients (ADC) and local recurrence and outcome in patients with brain metastases. The results showed that ADC values did not have a significant impact on local in-brain progression and survival parameters.

BRITISH JOURNAL OF NEUROSURGERY (2023)

Article Oncology

Current neurosurgical concepts in the resection of cerebral metastases

Marion Rapp, Daniel Haenggi, Michael Sabel

Summary: Cerebral metastases are common intracranial tumors in adults. Resection surgery can extend the survival of patients, even for metastases located in eloquent areas.

ONKOLOGE (2022)

Article Oncology

Would they do it again? Final treatment decisions in malignant brain tumour patients-a caregiver's perspective

Marion Rapp, Christiane von Sass, Clara Backhaus, Daniel Hanggi, Marcel Alexander Kamp, Michael Sabel

Summary: The last therapy decision for malignant brain tumor patients greatly affects the caregivers' perspective. Caregivers are more likely to support the same therapy decision if they had a positive evaluation of the last therapy and were satisfied with the informed consent. Good interpersonal contact is crucial for satisfaction with surgery and chemotherapy. Caregivers should play an important role in therapy discussions.

SUPPORTIVE CARE IN CANCER (2022)

Article Medicine, Research & Experimental

Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy-the MecMeth/NOA-24 trial

Thomas Zeyen, Anna-Laura Potthoff, Robert Nemeth, Dieter H. Heiland, Michael C. Burger, Joachim P. Steinbach, Peter Hau, Ghazaleh Tabatabai, Martin Glas, Uwe Schlegel, Oliver Grauer, Dietmar Krex, Oliver Schnell, Roland Goldbrunner, Michael Sabel, Niklas Thon, Daniel Delev, Hans Clusmann, Clemens Seidel, Erdem Gueresir, Matthias Schmid, Patrick Schuss, Frank A. Giordano, Alexander Radbruch, Albert Becker, Johannes Weller, Christina Schaub, Hartmut Vatter, Judith Schilling, Frank Winkler, Ulrich Herrlinger, Matthias Schneider

Summary: This study aims to evaluate the safety and efficacy of combined MFA/TMZ therapy in patients with recurrent MGMT-methylated glioblastoma. If successful, MFA may become the first clinically feasible targeted drug against TMs.

TRIALS (2022)

Article Oncology

Impact of Anticipated Awake Surgery on Psychooncological Distress in Brain Tumor Patients

Franziska Staub-Bartelt, Oliver Radtke, Daniel Haenggi, Michael Sabel, Marion Rapp

Summary: The study found that undergoing awake surgery for brain tumor patients does not lead to higher rates or scores of distress, anxiety, or depression. Additionally, whether the surgery is primary or recurrent did not have a significant impact on the prevalence or severity of these psychological factors.

FRONTIERS IN ONCOLOGY (2022)

Article Radiology, Nuclear Medicine & Medical Imaging

Cost Effectiveness of 18F-FET PET for Early Treatment Response Assessment in Glioma Patients After Adjuvant Temozolomide Chemotherapy

Jurij Rosen, Garry Ceccon, Elena K. Bauer, Jan-Michael Werner, Caroline Tscherpel, Veronika Dunkl, Marion Rapp, Michael Sabel, Ulrich Herrlinger, Alexander Heinzel, Niklas Schaefer, Maximilian Ruge, Roland Goldbrunner, Gabriele Stoffels, Christoph Kabbasch, Gereon R. Fink, Karl-Josef Langen, Norbert Galldiks

Summary: This study compared the effectiveness and cost effectiveness of F-18-FET PET with conventional MRI for identifying early responders to adjuvant temozolomide chemotherapy. The results showed that F-18-FET PET had a higher rate of correctly identifying responders and was cost-effective compared to MRI.

JOURNAL OF NUCLEAR MEDICINE (2022)

Article Oncology

Prognostic impact of obesity in newly-diagnosed glioblastoma: a secondary analysis of CeTeG/NOA-09 and GLARIUS

Johannes Weller, Niklas Schaefer, Christina Schaub, Anna-Laura Potthoff, Joachim P. Steinbach, Uwe Schlegel, Michael Sabel, Peter Hau, Clemens Seidel, Dietmar Krex, Roland Goldbrunner, Torsten Pietsch, Theophilos Tzaridis, Thomas Zeyen, Valeri Borger, Erdem Guresir, Hartmut Vatter, Ulrich Herrlinger, Matthias Schneider

Summary: Obesity is associated with shorter survival in patients with MGMT methylated glioblastoma, but not in patients with MGMT unmethylated glioblastoma.

JOURNAL OF NEURO-ONCOLOGY (2022)

Article Oncology

Mid-term treatment-related cognitive sequelae in glioma patients

Sabine Schloemer, Joerg Felsberg, Milena Pertz, Bettina Hentschel, Markus Loeffler, Gabriele Schackert, Dietmar Krex, Tareq Juratli, Joerg Christian Tonn, Oliver Schnell, Hartmut Vatter, Matthias Simon, Manfred Westphal, Tobias Martens, Michael Sabel, Martin Bendszus, Nils Doerner, Klaus Fliessbach, Christian Hoppe, Guido Reifenberger, Michael Weller, Uwe Schlegel

Summary: This study evaluates the effects of standard treatment modalities on neurocognitive functions in glioma patients within two years after surgery. The results show that radiotherapy, chemotherapy or their combination as standard treatment did not have a detrimental effect on cognitive functions in WHO grade 1-4 glioma patients during this period.

JOURNAL OF NEURO-ONCOLOGY (2022)

Article Oncology

In-Vitro Use of Verteporfin for Photodynamic Therapy in Glioblastoma

Sebastian Jeising, Gerd Geerling, Rainer Guthoff, Daniel Haenggi, Michael Sabel, Marion Rapp, Ann-Christin Nickel

Summary: This study demonstrates that PDT with the second-generation photosensitizer VP causes cell death in GBM cells. It also validates the cellular uptake of VP in GBM cells and suggests its potential use as an optical imaging dye in surgery.

PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY (2022)

Article Medicine, Research & Experimental

Evaluate the safety and efficacy of dura sealant patch in reducing cerebrospinal fluid leakage following elective cranial surgery (ENCASE II): study protocol for a randomized, two-arm, multicenter trial

Andrew P. Carlson, Emma M. H. Slot, Tristan P. C. van Doormaal, E. H. J. Voormolen, J. W. Dankbaar, P. Depauw, B. Brouwers, M. R. Germans, E. Baert, J. Vandersteene, C. F. Freyschlag, J. Freyschlag, C. Thome, F. Zenga, F. Penner, A. Abdulazim, M. Sabel, M. Rapp, T. Beez, M. Zuccarello, E. Sauvageau, K. Abdullah, B. Welch, D. Langer, J. Ellis, A. Dehdashti, J. VanGompel, B. Bendok, K. Chaichana, J. Liu, A. Dogan, M. K. Lim, M. G. Hayden

Summary: This study aims to assess the safety and effectiveness of a novel dural sealant patch (LIQOSEAL) in reducing CSF leakage in patients undergoing neurosurgery. A randomized controlled trial will be conducted with a total of 228 patients. The primary endpoint includes intraoperative and postoperative CSF leakage, wound infection, and pseudomeningocele.

TRIALS (2022)

Article Oncology

Two Decades of Brain Tumour Imaging with O-(2-[18F]fluoroethyl)-L-tyrosine PET: The Forschungszentrum Julich Experience

Alexander Heinzel, Daniela Dedic, Norbert Galldiks, Philipp Lohmann, Gabriele Stoffels, Christian P. Filss, Martin Kocher, Filippo Migliorini, Kim N. H. Dillen, Stefanie Geisler, Carina Stegmayr, Antje Willuweit, Michael Sabel, Marion Rapp, Michael J. Eble, Marc Piroth, Hans Clusmann, Daniel Delev, Elena K. Bauer, Garry Ceccon, Veronika Dunkl, Jurij Rosen, Caroline Tscherpel, Jan-Michael Werner, Maximilian I. Ruge, Roland Goldbrunner, Jurgen Hampl, Carolin Weiss Lucas, Ulrich Herrlinger, Gabriele D. Maurer, Joachim P. Steinbach, Joerg Mauler, Wieland A. Worthoff, Bernd N. Neumaier, Christoph Lerche, Gereon R. Fink, Nadim Jon Shah, Felix M. Mottaghy, Karl-Josef Langen

Summary: PET imaging using O-(2-[F-18]fluoroethyl)-L-tyrosine (FET) as a tracer has become essential for diagnosing brain tumors, with increasing demand seen for differentiating tumor progress and treatment-related changes. Referring physicians rate FET PET highly for diagnosing recurrent gliomas and brain metastases.

CANCERS (2022)

Review Oncology

Stereotactic Radiosurgery for Benign Cavernous Sinus Meningiomas: A Multicentre Study and Review of the Literature

Antonio Santacroce, Constantin Tuleasca, Roman Liscak, Enrico Motti, Christer Lindquist, Matthias Radatz, Brigitte Gatterbauer, Bodo E. Lippitz, Roberto Martinez Alvarez, Nuria Martinez Moreno, Marcel A. Kamp, Bente Sandvei Skeie, Stephanie Schipmann, Michele Longhi, Frank Unger, Ian Sabin, Thomas Mindermann, Otto Bundschuh, Gerhard A. Horstmann, A. T. C. J. van Eck, Maja Walier, Manfred Berres, Makoto Nakamura, Hans Jakob Steiger, Daniel Haenggi, Thomas Fortmann, Samer Zawy Alsofy, Jean Regis, Christian Ewelt

Summary: Meningiomas are common tumors of the central nervous system, and cavernous sinus meningiomas (CSMs) require special treatment due to their location. Stereotactic radiosurgery (SRS) has been found to be a safe and effective alternative for the treatment of CSMs. This multicenter study analyzed the outcomes of over 1000 patients with CSMs treated with SRS, and found that SRS achieved a high tumor control rate with few complications.

CANCERS (2022)

Article Oncology

Patterns, predictors and prognostic relevance of high-grade hematotoxicity after temozolomide or temozolomide-lomustine in the CeTeG/NOA-09 trial

J. Weller, N. Schaefer, C. Schaub, T. Tzaridis, T. Zeyen, M. Schneider, A. L. Potthoff, F. A. Giordano, J. P. Steinbach, P. S. Zeiner, T. Kowalski, M. Sabel, P. Hau, D. Krex, O. Grauer, R. Goldbrunner, O. Schnell, G. Tabatabai, F. Ringel, F. Schmidt-Graf, S. Brehmer, J. C. Tonn, L. Bullinger, P. Vajkoczy, M. Glas, H. Vatter, U. Herrlinger, C. Seidel

Summary: In the CeTeG/NOA-09 randomized phase III trial, TMZ/CCNU combination therapy was found to be superior to TMZ in newly diagnosed MGMT methylated glioblastoma, with higher incidence of hematotoxicity. This study analyzed high-grade hematotoxicity and its prognostic relevance in the trial population.

JOURNAL OF NEURO-ONCOLOGY (2023)

Article Oncology

Impact of COVID-19 Epidemic on Psycho-Oncological Distress in Neuro-Oncological Patients

Franziska Staub-Bartelt, Julia Steinmann, Oliver Radtke, Daniel Haenggi, Michael Sabel, Marion Rapp

Summary: The COVID-19 pandemic does not significantly affect the prevalence of distress, anxiety, and depression in neuro-oncological patients. There is no significant difference in the rates of these psychological issues compared to before the pandemic.

CURRENT ONCOLOGY (2023)

暂无数据